GMP – MHRA Inspectorate

Pharmacovigilance unravelled: highlights of the 2024 MHRA GPvP Symposium

Zoe Hamill, 4 April 2024 - Good pharmacovigilance practice, Inside the Inspectorate

The world of GPvP is highly regulated, but the 2024 GPvP symposium showcased how regulation, collaboration and innovation can work together to enhance compliance, provide opportunities for better ways of working, and improve patient lives. The Symposium welcomed over five …

Pilot GMP Single Inspection Program

Ian Jackson, 20 February 2024 - Good manufacturing practice

Launch of a pilot Single Inspection Program, a global approach to GMP inspections of third country manufacturers. Health Canada, the Therapeutic Goods Administration (TGA) and the Medicines & Healthcare products Regulatory Agency (MHRA), all members of the Pharmaceutical Inspection Co-operation Scheme …

Return to International GMP Inspections

grahamcarroll, 8 November 2022 - Good manufacturing practice

In March 2020 the MHRA Inspectorate published a blog post in which we announced that until further notice we would only conduct on-site inspections linked to the UK Government’s COVID-19 response or any other potential serious public health risk. In …

Pharmacovigilance unravelled: highlights of the 2024 MHRA GPvP Symposium

Pilot GMP Single Inspection Program

Return to International GMP Inspections

About the MHRA Inspectorate Blog

Categories

Follow us on social media

Sign up and manage updates

Printing Posts

Other MHRA Blogs

Comments and moderation

Recent posts

Related content and links